Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non‑Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast

Affiliations

• ¹ The University of Texas MD Anderson Cancer Center, Houston, TX, USA. xle1@mdanderson.org.
• ² Baylor University Medical Center, Dallas, TX, USA.
• ³ Division of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
• ⁴ The University of Texas MD Anderson Cancer Center, Houston, TX, USA.